Insider track record
OtherAcross 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Reardon Andrew. Insider active across 1 company, notably Ligand Pharmaceuticals INC. Aggregated, 13 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €19k. History available since 30 November 2022. The latest transaction was disclosed on 4 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
6,415 shares0Common StockSEC:0002001011-25-000016:0
6,928 shares0Common StockSEC:0002001011-25-000010:0
2,000 shares@ US$52.2710.8% of flowCommon StockSEC:0002001011-24-000089:0
1,500 shares@ US$52.278.1% of flowCommon StockSEC:0002001011-24-000079:0
329 shares@ US$60.7072.1% of flowCommon StockSEC:0002001011-24-000065:0
10,000 shares@ US$52.2755.7% of flowCommon StockSEC:0002001011-24-000051:0
7,208 shares0Common StockSEC:0002001011-24-000030:0
593 shares@ US$74.654.7% of flowCommon StockSEC:0002001011-24-000019:0
179 shares@ US$60.7071.1% of flowCommon StockSEC:0002001011-24-000010:0
897 shares@ US$68.736.5% of flowCommon StockSEC:0000886163-23-000051:0
300 shares@ US$69.92432.2% of flowCommon StockSEC:0000899243-23-009799:0
5,668 shares0Common StockSEC:0000899243-23-006296:0
1,073 shares@ US$72.908.7% of flowCommon StockSEC:0000899243-22-037324:0